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http://www.particleandfibretoxicology.com/content/10/1/61RESEARCH Open AccessDiesel exhaust particulate increases the size and
complexity of lesions in atherosclerotic mice
Mark R Miller1*, Steven G McLean1, Rodger Duffin2, Akeem O Lawal3, Jesus A Araujo3, Catherine A Shaw1,
Nicholas L Mills1, Ken Donaldson2, David E Newby1 and Patrick WF Hadoke1Abstract
Objective: Diesel exhaust particulate (DEP), a major component of urban air pollution, has been linked to
atherogenesis and precipitation of myocardial infarction. We hypothesized that DEP exposure would increase and
destabilise atherosclerotic lesions in apolipoprotein E deficient (ApoE−/−) mice.
Methods: ApoE−/− mice were fed a ‘Western diet’ (8 weeks) to induce ‘complex’ atherosclerotic plaques, with parallel
experiments in normal chow fed wild-type mice. During the last 4 weeks of feeding, mice received twice weekly
instillation (oropharyngeal aspiration) of 35 μL DEP (1 mg/mL, SRM-2975) or vehicle (saline). Atherosclerotic burden
was assessed by en-face staining of the thoracic aorta and histological examination of the brachiocephalic artery.
Results: Brachiocephalic atherosclerotic plaques were larger in ApoE−/− mice treated with DEP (59±10%) than
in controls (32±7%; P = 0.017). In addition, DEP-treated mice had more plaques per section of artery (2.4±0.2 vs
1.8±0.2; P = 0.048) and buried fibrous layers (1.2±0.2 vs 0.4±0.1; P = 0.028). These changes were associated with
lung inflammation and increased antioxidant gene expression in the liver, but not with changes in endothelial
function, plasma lipids or systemic inflammation.
Conclusions: Increased atherosclerosis is caused by the particulate component of diesel exhaust producing
advanced plaques with a potentially more vulnerable phenotype. These results are consistent with the
suggestion that removal of the particulate component would reduce the adverse cardiovascular effects of
diesel exhaust.
Keywords: Diesel, Air pollution, P, Atherosclerosis, ApoE, Oxidative stressBackground
Particulate matter (PM) air pollution is associated with
an increase in cardiovascular morbidity and mortality [1,2].
In epidemiologic studies, residents of areas with high air
pollution have evidence of increased atherosclerosis [3-6].
This relationship is supported by pre-clinical studies show-
ing that exposure to traffic-derived pollutants can increase
atherosclerotic lesion size and alter lesion composition
(comprehensively reviewed in [7]). The mechanisms re-
sponsible for these changes remain unclear, but there is
evidence implicating altered endothelial cell function
[8] and increased oxidative stress [9-11].* Correspondence: mark.miller@ed.ac.uk
1Centre for Cardiovascular Sciences, University of Edinburgh, 47 Little France
Crescent, EH16 4TJ Edinburgh, Scotland, UK
Full list of author information is available at the end of the article
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reproduction in any medium, provided the orDiesel exhaust (DE) emissions are the major source of
nanoparticles in the urban environment that, while con-
tributing little to the airborne mass, produce very high
numbers of ambient particles and a large reactive surface
area, as well as the potential to deposit throughout the
lungs [12,13]. We have previously shown that inhalation
of environmentally-relevant concentrations of DE impairs
endothelial and fibrinolytic function [14,15], promotes
blood thrombogenicity [16] and exacerbates cardiac
ischemia [17] in man. Inhaled DE also promotes athero-
sclerosis in mice [10,18-20]. Importantly, the procoagulant
changes and impairment of vascular function induced by
DE can be prevented by filtration [21,22], consistent with
the hypothesis that the particulate component of DE
drives the adverse cardiovascular effects (reviewed in
[23]). To date, no investigation has directly determined
the effect of diesel exhaust particulate (DEP) on thetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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addressed the hypothesis that exposure to DEP would
increase lesion size and complexity in a murine model
of atherosclerosis, and that this would be mediated by
inflammation, endothelial dysfunction and oxidative stress.
Results
Instillation and pulmonary inflammation
Pulmonary instillation of DEP was chosen as the exposure
method; to administer only the particulate components
of diesel exhaust, to ensure the complete delivery of the
dose to the lungs, and establish this model as a basis
for future experiments looking at the effects of fraction-
ated DEP. Instillation was well tolerated, with no mor-
tality and no effect on body weight (Additional file 1:
Figure S1). Lungs of DEP-instilled mice showed fibrotic
thickening of the alveolar septae and cuffing of alveolar
blood vessels (Figure 1a,b). Particulate was visible deep
in the airways, largely within alveolar macrophages. In-
stillation of DEP produced similar increases in the total
cell count in bronchoalveolar lavage fluid (BALF) from
atherosclerosis-prone apoliprotein E knockout (ApoE−/−)
mice to that from wild-type (C57bl6) mice (P < 0.03, un-
paired t-test; n = 7-9; Figure 1c). Macrophages were the
predominant cell type in BALF (Figure 1d), although DEP
also increased the number of neutrophils (P < 0.011) but
not lymphocytes (P > 0.23) in both strains (n = 7-9 for all).
DEP had no effect on interleukin-6 (IL-6; P > 0.13; n = 4-6Figure 1 Instillation of DEP induces pulmonary inflammation and alveo
and (b) DEP-instilled ApoE−/− mice showing airway fibrosis and cuffing of pul
macrophages deep within the airspaces. Scale bars = 100 μm. (c) Total cell co
*P < 0.05, **P < 0.01, unpaired t- test comparing DEP with saline control in sam
wild-type mice were fed normal chow.for all), tumour necrosis factor alpha (TNFα; P > 0.25;
n = 4-5 for C57bl6, n = 6-7 for ApoE−/−) or monocyte
chemotactic protein-1 (MCP-1; CCL2/JE; P > 0.23;
n = 4-5 for all) levels in BALF (Additional file 1: Table S2).
Distribution and size of atherosclerotic plaques
Aortae from C57bl6 mice exhibited little Sudan IV
staining in either the saline- or DEP-instilled groups. In
saline-treated ApoE−/− mice, lipid-rich lesions were
visible on the surface of the thoracic aorta largely con-
fined to the aortic arch (Figure 2a). Lipid incorporation
was greater in DEP- than saline-instilled ApoE−/− mice
(P = 0.046, n = 6-7; Figure 2b).
The brachiocephalic artery, which develops complex
atherosclerotic plaques, was chosen for histological ana-
lysis [24]. No lesions were evident in C57/bl6 mice
(saline, n = 3; DEP, n = 5). In contrast, ApoE−/− mice
developed large lesions throughout the length of the
brachiocephalic artery, particularly in the 400 μm prox-
imal to the bifurcation of the aortic arch (Figure 2c). Mean
plaque size was markedly increased (P = 0.017) in DEP-
treated ApoE−/− mice (59±10%, n = 7) compared with
controls (32±7%, n = 9; Figure 2d). This increase was
seen using several different measures of lesion size
(Additional file 1: Table S3). The size of atherosclerotic
lesions was associated with levels of pulmonary inflam-
mation (BALF total cell count) on the day of necropsy
(P = 0.004, n = 16; Figure 2e).lar remodelling. Representative lung sections from (a) saline-instilled
monary blood vessels. Inset: High power image showing particle-laden
unts in BALF. (d) Cell differentials in BALF. Mean ± S.E.M. (n = 7-9 for all)
e animal type. ApoE−/− were fed Western diet for 8 weeks, whereas
Figure 2 Instillation of DEP increases atherosclerosis. (a) Representative images showing lipid-rich lesions in the aorta following staining with
Sudan IV (red stain; orange is non-specific staining). Scale bars = 1 mm. (b) Percentage of the intimal surface staining positive for lipids. Mean ± S.E.M.
(n = 3-4 for C57bl6, n = 6-7 for ApoE−/−), *P < 0.05, Mann–Whitney test, saline vs DEP in ApoE−/− mice. (c) Representative transverse sections of
atherosclerotic plaques in the brachiocephalic artery stained with United States Trichrome (UST). Scale bars = 100 μm. (d) Plaque size, as a
percentage of medial area was increased in DEP-treated ApoE−/− mice. Mean ± S.E.M. (n = 3-5 for C57bl6, n = 7-9 for ApoE−/−), *P < 0.05, unpaired
t-test, saline vs DEP in ApoE−/− mice. Mean value obtained from analysis of serial sections at 100 μm intervals for each animal; Mean number of
sections per group = 4.4 ± 0.6 for ApoE-saline (n = 9), 4.4 ± 0.8 for ApoE-DEP (n = 7). ApoE−/− were fed Western diet for 8 weeks, whereas wild-type
mice were fed normal chow. (e) Plaque size in the brachiocephalic artery correlated with the extent of pulmonary inflammation (BALF total cell
count) at time of necropsy (R2 = 0.45, P = 0.0043, n = 16).
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Plaque composition was studied in detail to provide
insight into the potential ability of DEP to promote plaque
instability. ApoE−/− mice developed complex atheroscler-
otic lesions with variable proportions of smooth musclecells, foam cells, lipid, cholesterol crystals and fibrous tis-
sue (Figure 3). Exposure to DEP had little effect on lesion
composition (n = 5-6/group; Additional file 1: Figure S2).
Quantification of foam cells (MAC-2-positive), lipid
cavities, smooth muscle cells and collagen (Figure 3a-d)
Figure 3 Assessment of plaque composition and structure. Representative brachiocephalic plaque sections showing (a) lipid cavities: plaque
regions showing absence of all components of UST stain, (b) inflammatory cells: MAC2 immunohistochemistry (brown), (c) collagen: picrosirius
red (red stain), (d) smooth muscle: SMA immunohistochemistry (brown). Scale bar = 100 μm. (e) Example of a large atherosclerotic plaque from a
saline-treated ApoE−/− mouse, showing only a single plaque per section and no buried fibrous layers. (f) Example of three buried fibrous layers in
a plaque (black, green and red arrows mark each fibrous layer) taken from a DEP-treated ApoE−/− mouse. UST staining, scale bar = 100 μm.
(g) DEP instillation increased the average number of distinct plaques within each cross-section of lesion and the number of buried fibrous
layers per section. Mean ± S.E.M. Values obtained from analysis of serial sections at 100 μm intervals for each animal; Mean number of sections per
group = 4.4 ± 0.7 for ApoE-saline (n = 8), 4.4 ± 0.8 for ApoE-DEP (n = 7), *P < 0.05, Mann–Whitney test comparing saline with DEP. All images shown are
from arteries from DEP-instilled ApoE−/− mice, except panel 3e, taken from saline-treated ApoE−/− mouse.
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ApoE−/− mice (n = 7-9/group; Additional file 1: Figure S2).
Similarly, no differences were detected in the levels of
matrix metalloproteinases (MMP-2 and MMP-9; saline
n = 9, DEP n = 4; Additional file 1: Figure S3) or fibrin/
fibrinogen (Additional file 1: Figure S4) in the plaques
of DEP-treated mice (n = 5-6/group for all). However,
DEP-treated animals had a greater number of distinct
plaques per section of lesion (2.4±0.2 plaques) compared
with saline-treated controls (1.8±0.2 plaques; P = 0.022,
n = 7-8, Figure 3e-g). DEP also trebled the frequency
of buried fibrous layers per section of lesion (1.2±0.2
vs 0.4±0.1; P = 0.013, n = 7-8; Figure 3e-g).
Blood lipids, C-reactive protein and fibrinogen
Serum cholesterol concentrations were increased in
ApoE−/− mice fed a Western diet (20.1±0.7 mM) com-
pared to C57bl6 mice fed standard chow (1.3±1.5 mM;
n = 16, combined saline and DEP, for both genotypes;
P < 0.001, Figure 4a) whereas serum triglyceride con-
centrations were similar in both ApoE−/− (0.34±0.03 mM)
and C57bl6 mice (0.36±0.02 mM; n = 16, combined saline
and DEP, for both genotypes; Figure 4b). Both variablesFigure 4 DEP instillation did not alter lipid or markers of systemic inf
(n = 10), (b) serum triglyceride (n = 10), (c) serum CRP (n = 8) and (d) plasm
C57bl6 vs ApoE; nsP > 0.05, Bonferroni post-hoc tests, following one-way AN
mice were fed normal chow.were unaffected by DEP instillation. Similarly, serum
C-reactive protein (CRP) and plasma fibrinogen con-
centrations were unaffected by DEP instillation (both
P > 0.05; n = 8 for all; Figure 4c,d; Additional file 1:
Table S2). Total and active tissue plasminogen activator
(t-PA) levels were below the limit of detection (n = 7-8
for all; Additional file 1: Table S2).Vascular function
To determine whether DEP-instillation caused endothelial
dysfunction, aortic rings were isolated for functional ana-
lysis. Phenylephrine caused an identical concentration-
dependent contraction in C57bl6 and ApoE−/− mice and
was unaltered by DEP instillation (P > 0.24, DEP vs saline;
n = 6-7; Figure 5a). Relaxations to the endothelium-
dependent vasodilator, acetylcholine, or the endothelium-
independent nitric oxide (NO) donor, sodium nitroprusside
(SNP), were unaffected by DEP-instillation in C57bl6 and
ApoE−/− mice (P > 0.29; n = 4-5 for all; Figure 5b,c). Similar
responses to relaxants were seen if the arteries were pre-
contracted with noradrenaline rather than phenylephrine
(n = 3-7; Additional file 1: Figure S5).lammation and coagulation within the blood. (a) Serum cholesterol
a fibrinogen (n = 8) levels. Mean ± S.E.M. ***P < 0.001, unpaired t-test of
OVA. ApoE−/− were fed Western diet for 8 weeks, whereas wild-type
Figure 5 Vascular function was unchanged by DEP instillation.
(a) Contraction of aortic rings to phenylephrine, (b) endothelium-
dependent relaxation to acetylcholine and (c) endothelium-independent
relaxation to sodium nitroprusside. Responses in C57bl6 mice (grey lines)
or ApoE−/− mice (black lines) receiving either saline (circles, broken line) or
DEP (triangles, solid line) instillation. All dose response curves were
performed in the same vessel from a single animal. ApoE−/− were
fed Western diet for 8 weeks, whereas wild-type mice were fed normal
chow. Mean ± S.E.M. (n = 6-7 for phenylephrine, n = 4-5 for
acetylcholine and SNP), n.s.P> 0.05, two-way ANOVA saline vs DEP in
C57bl6 mice, N.S.P> 0.05, two-way ANOVA saline vs DEP in ApoE−/− mice. Figure 6 Instillation of DEP increased expression of antioxidant
genes in the liver, particularly in ApoE−/− mice. (a) NF-E2-related
factor-2 (Nrf2), (b) NAD(P)H-quinone oxidoreductase-1 (NQO1) and
(c) hemeoxygenase-1 (HO-1). Effect of DEP shown as fold-increase in
the expression in saline-treated mice. Mean ± S.E.M. (n = 5-8), n.s.P> 0.05,
*P< 0.05, ***P< 0.001, unpaired t-test comparing saline vs DEP. ApoE−/−
were fed Western diet for 8 weeks, whereas wild-type mice were fed
normal chow.
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Expression of antioxidants in liver was used to as an
indicator of a response to a systemic oxidative stress.
Instillation of DEP increased NF-E2-related factor-2
(Nrf2) expression in C57bl6 mice (P < 0.01; n = 5 for all;
Figure 6). Exposure to DEP induced an increase in gene
expression of Nrf2 (P = 0.023; n = 5 for all), NAD(P)H-
quinone oxidoreductase 1 (NQO1; P=0.034; n = 7 for C57bl6
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(HO-1; P = 0.027; n = 8 for all) in ApoE−/− mice (Figure 6).
Discussion
We have here demonstrated that, in the murine apolipo-
protein E deficiency model, instillation of DEP increased
lesion size, produced more lesions per vessel and gener-
ated more buried fibrous caps. The proatherosclerotic
effect was concomitant with pulmonary inflammation
and systemic oxidative stress. We conclude that the par-
ticulate components of DE accelerate plaque develop-
ment and are associated with a more complex plaque
phenotype. The processes involved may contribute to the
association between exposure to urban air pollution,
atherosclerosis and acute myocardial infarction in man.
The influence of DEP was assessed using a recognised
model of atherosclerosis at a period of extensive plaque
expansion and remodelling [25,26]. Serial sections of
artery were used to provide a surrogate marker of plaque
volume and a sensitive approach to quantifying changes
in plaque burden. We found that four weeks of repeated
DEP exposure caused an almost doubling of plaque size
from 32% to 59%. The 4-week exposure to DEP was
consistent with pre-clinical investigations using concen-
trated ambient particles (CAPs) [8,9,27-30], whole DE
[11,19] and, to a lesser extent, non-carbon nanoparticles
[31]. These previous studies have been performed in
several different animal models (ApoE−/− mice, low dens-
ity lipoprotein receptor Apo E double knockout mice and
Watanabe heritable hyperlipidaemic rabbits) using either
inhalation [8,10,11,19,30] or instillation [27,29,31]. The
present study is the first to assess whether direct exposure
to DEP increases atherosclerosis.
The marked increases in plaque size with DEP instilla-
tion are striking given the short duration of the exposure
period. In the present study, long-term exposure has been
emulated by administration of higher doses of particles
over a shorter length of time. The instillation technique
has been well validated [32-36] and the dose employed is
similar to that of other studies using repeated instillations
[37,38], and below those commonly used for single instil-
lation exposures. While we cannot rule out that a propor-
tion of the particulate administered deposits in the upper
airways, studies have shown that the aspiration instillation
technique to provide excellent delivery and dispersity of
particulate throughout the alveoli [39,40]. The MPPD par-
ticle deposition model [41] estimates that the average 24-h
instilled dose used here (assuming all DEP reaches the
alveoli) is approximately 40-fold higher than the com-
parable alveolar deposition from a 24-h inhalation of
100 μg/m3 in man (adjusted for mice). It is important to
highlight that these calculations are based on inhalation
of particles with a primary particle diameter of that of
diesel exhaust (~60 nm), whereas, urban levels of airpollution will contain a wide range of particulate sizes
of which only a lower proportion of the larger particu-
lates will penetrate past the tracheobronchial regions.
Nevertheless, it is estimated that ~20% (6-41%; [42,43])
of the mass of PM2.5 is in the ultrafine range, and con-
centrations frequently reach 100 μg/m3 (a high percent-
age of which will originate from vehicle exhaust) for
sustained periods in heavily polluted cities in both de-
veloped and developing nations. Furthermore, the air-
borne mass concentration of 100 μg/m3 represents a
moderate/high PM levels over a 24-h period and does
not take into account peaks in PM levels that regularly
occur in cities, or the increased PM deposition produced
by exercise such as brisk walking or cycling in urban envi-
ronments. In comparison to a long-term continuous
inhalation, the instillation regimen will unavoidably induce
intermittent very high doses and dose-rate interspersed
with long periods of non-exposure [44]. Nevertheless, the
similarity of the current results with that of DE inhalation
in ApoE−/− mice [10,11,19,20,45] supports the contention
that the biological pathways identified using the instillation
protocol are both relevant and important. While a role
for the gaseous component of DE cannot be excluded,
our results suggest that the particulate component of
DE alone is sufficient to enhance plaque formation. It is
possible that the gaseous constituents could drive other
responses leading to altered plaque composition [10]
which we did not see in our study. The large magnitude
of the pro-atherosclerotic effect of DEP will allow us to
use this model in the future to explore which attributes
and constituents of DEP (e.g. transition metals, polyaro-
matic hydrocarbons and quinones), and urban PM in
general, are responsible for these effects.
Transient exposure to road-traffic has been linked to acute
coronary events [46] and several pre-clinical investigations
have suggested that exposure to atmospheric pollution in-
creases markers of lesion vulnerability [8,10,11,27,29]. Urban
PM [8,27,30,47,48], whole DE [11,19,20] or the gaseous
components of DE [10], increase lipid content and inflam-
matory cells in plaques and the underlying vessel wall. Our
results indicated that lipid and inflammatory cells increased
in lesions from DEP-instilled mice, but only in propor-
tion to lesion size.
While there was no change in the proportion of indi-
vidual plaque constituents, or other typical markers
associated with plaque vulnerability (e.g. MMPs), the
complexity of the lesions in DEP-instilled mice was
increased, with more lesions per section and more buried
caps within lesions compared with controls. The results
are similar to that previously observed in ApoE−/− mice
exposed to whole DE by inhalation: an effect that was
prevented by addition of a cerium additive to the diesel
fuel that decreased the number of particles in the ex-
haust [20]. It has been suggested that the presence of
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signs of plaque erosion or a previous plaque rupture
[49,50]. The question as to whether buried fibrous layers
are evidence of plaque rupture, or is merely a feature
of the on-going development of a single plaque, re-
mains a subject of debate [25,51]. Atherosclerotic lesions
in ApoE−/− mice do not rupture catastrophically, but
similar changes in human lesions would be associated
with increased plaque vulnerability [48,52]. Thus, these
findings would suggest that the ability of DEP to in-
crease plaque size and complexity are likely to be an
important contributor to the cardiovascular manifesta-
tions of urban air pollution in man.
Previous investigations have suggested that increased
atherosclerosis following exposure to DE or CAPs may
be due to increased systemic inflammation [11,27-29],
vascular dysfunction [8,19,30], or increased oxidative stress
[9-11,30]. In the current investigation, DEP did not increase
circulating concentrations of plasma lipids or plaque lipid
content, therefore, the exacerbation of lesion formation
cannot be attributed to altered lipid handling.
It has been hypothesised that inhaled particles exert
their cardiovascular effects indirectly through the passage
of inflammatory mediators from the lung to the systemic
circulation [53]. DEP caused a clear lung inflammation
characterised by infiltration of macrophages and neutro-
phils into the airways. Interestingly, there was an associ-
ation with levels of lung inflammation and the size of
atherosclerotic plaques. Other studies have failed to find
an association between the ability of nanoparticles to
induce pulmonary inflammation and their actions on a
range of cardiovascular end-points (reviewed in [54]).
Concentrations of acute phase proteins (CRP) in the
blood were unchanged by DEP exposure. Although we
cannot exclude transient surges in cytokines in response
to the particulate, or the involvement of other cytokines
(e.g. tumour necrosis factor alpha, interleukins, serum
amyloid A3), we have not found consistent changes in any
blood cytokine at either early (2 h) or late (24 h) time-
points after DE exposure in man [14,15,55]. Future studies
will address these possibilities in more detail. Additionally,
in the present study DEP did not change the inflammatory
cell content of atherosclerotic plaques, a finding similar
to that after 40 days inhalation of CAPs [9]. Overall,
while inflammatory pathways are likely to contribute to
the cardiovascular effects of DEP, neither pulmonary
nor systemic inflammation alone can account for the
atherogenic actions of DEP.
Repeated instillation of DEP was not associated evidence
of vascular dysfunction. Previous investigations have re-
ported increased [8,19] or reduced [30] vascular contract-
ility accompanying atherosclerosis following pollutant
exposure. There have also been contradictory indications
of normal [30] or impaired [8] acetylcholine-mediatedrelaxation. However, in the latter, the magnitude of the
impairment was small and followed prolonged (>10 weeks)
exposure and high-fat feeding. Alternatively, vasomotor
impairment may be restricted to resistance arteries [56]
and not the large conductance arteries where athero-
genesis takes place. Our results suggest that vascular
dysfunction is not required for DEP-induced acceler-
ation of atherosclerosis.
The hepatic up-regulation of several protective anti-
oxidant genes in response to DEP suggests a counter-
regulatory response to the systemic pro-oxidative effects
of DEP. We have previously shown that the Nfr2 path-
way is also upregulated in systemic tissues in response
to inhalation of ultrafine urban PM in ApoE−/− mice [9]
and whole diesel exhausts [45]. Interestingly, up-regulation
of Nrf2 could trigger vascular proatherogenic effects as
we have recently reported that systemic Nrf2 deletion
inhibits rather than promotes atherosclerotic lesion for-
mation in the aorta of ApoE null mice [57]. DEP itself
can generate free radicals in solution [58], and oxidative
stress is one of the most consistently proposed links be-
tween the pulmonary and systemic effects of particulate
exposure [59]. Vehicle exhaust promotes lipid peroxida-
tion in plasma lipoproteins and systemic tissues [60],
consistent with recent studies where DE led to increased
plasma levels of 8-isoprostanes, 12-HETEs, 13-HODEs,
the development of dysfunctional prooxidative and pro-
inflammatory high density lipoprotein (HDL) [45], and
increased isoprostanes in urine [11]. Although we did
not evaluate the status of lipid peroxidation in our
study, we suggest that the systemic pro-oxidative effects
of the particulates in DE could drive a significant por-
tion of the proatherosclerotic actions of urban PM.
Interestingly, antioxidant upregulation was especially
notable in ApoE−/− mice compared to wild-type mice.
This observation adds to the growing evidence that
animals/individuals with pre-existing vascular disease (or
their risk factors), or diseases with associated cardiovascu-
lar complications (e.g. diabetes), may be particularly sus-
ceptible to the effects of air pollution [1,7,61,62].
Conclusions
Exposure of the particulate constituents of diesel exhaust
increases both the size and complexity of atherosclerotic
plaques in vivo, and may therefore increase the suscepti-
bility of plaques to rupture. The increased atherogenesis
was not directly related to raised levels of systemic in-
flammation, changes in lipid handling or endothelial
dysfunction, but was associated with pulmonary inflam-
mation and systemic changes in antioxidant expression.
Similar changes in man would be predicted to increase
plaque vulnerability and rupture, helping to explain the
associations between urban air pollution and acute myo-
cardial infarction. These findings provide support for the
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particulate emissions as a means to reduce the detrimen-
tal health effects of air pollution.
Methods
Detailed Methods in Additional file 1.
Animals, instillations and necropsy
All experiments were performed according to the Animals
(Scientific Procedures) Act 1986 (UK Home Office). Adult
male ApoE−/− mice (N = 20) and the background strain
(C57bl6 mice; N = 16) were purchased from Charles River
(Margate, UK) aged 8–9 wks (20–25 g). C57bl6 mice were
fed 8 weeks standard chow, whereas ApoE−/− mice re-
ceived a high fat ‘Western Diet’ (21% fat; Research Diets,
New Brunswick, USA). This approach was used to allow a
direct comparison of the effect of DEP on animals with no
atherosclerosis with that of animals exhibiting large ‘com-
plex’ atherosclerotic plaques, respectively.
For the final four weeks of feeding, mice underwent
twice weekly instillation (oropharnyngeal aspiration) of
35 μg DEP (35 μL of 1 mg/mL; National Institute of Stan-
dards and Technology (NIST); SRM-2975; Gaithersburg,
U.S.A.), to represent an average daily dose of 10 μg/mouse
(see Discussion). This reference material is a commonly
used source of DEP, allowing comparability with other
researchers, and we have previously shown it has the
capacity to generate superoxide free radicals in vitro,
stimulate cultured macrophages and can directly impair
arterial function [58,63]. The mean particle size of DEP
in saline buffer prior to administration was 257 ± 46 nm
(n = 6; dynamic light scattering, Brookhaven PS90 Particle
Size Analyser; data not shown). Animals were sacrificed
3–4 days after their last instillation and blood (0.6-1 mL)
withdrawn from the heart. Lungs were lavaged with sterile
saline (3x 0.8 mL) to collect bronchoalveolar lavage fluid
(BALF), and the carotid arteries, brachiocephalic artery,
aortic arch, thoracic aorta and liver biopsies collected.
Measures of pulmonary inflammation
BALF samples were centrifuged (180 g, 5 min, 4°C) and
the cell pellets combined, resuspended, stained with
Diff-Quik (Raymond A Lamb, London, UK) and prepared
into cytocentrifuge smears for differential cell counts. The
inflammatory cytokines interleukin-6 (IL-6), tumour
necrosis factor alpha (TNF-α) and monocyte chemo-
tactic protein-1 (MCP-1; CCL2/JE) were measured in
the primary cell-free BALF by enzyme-linked immuno-
sorbent assay (ELISA; R&D Duoset Systems; Patricell
Ltd, Nottingham, UK).
Assessment of atherosclerosis
The aortic arch and descending thoracic aorta were
randomly selected from half of the mice from eachtreatment group. The artery was cut longitudinally and
lipid-rich atherosclerotic plaques were stained en-face
using Sudan IV.
Brachiocephalic arteries were fixed in formalin and
histological sections were taken in triplicate at 100 μm
intervals, beginning at the first section of artery with a fully
intact media. Sections were stained with United States
Trichrome (UST). The cross-sectional area of the plaque
was measured and standardised to the medial area. The
medial wall was chosen for standardisation rather than
luminal area, as vessels could not be perfusion-fixed
in situ, as they were also required for assessment of
vascular function by myography (see below). A single
mean value of atherosclerotic burden for each animal was
calculated from the plaque size from each complete serial
section throughout the brachiocephalic artery.
Plaque composition was assessed by both semi-
quantitative scoring of fibrous matrix, foam cell and
lipid content, and thickness of plaque cap, in UST-stained
sections. Quantitative measurement of plaque constitu-
ents was performed using histology (collagen, fibrin) and
immunohistochemistry (lipids, macrophages, smooth muscle
cells, fibrinogen, metalloproteinases).
Plaque structure was assessed by counting distinct ad-
joining, or overlying, plaques within each section [20].
Additionally, the number of buried fibrous layers (defined
as ‘a length of fibrous/cellular matter that completely
bisects a lipid-rich regions of two overlying plaque sec-
tions [24]) was counted in each section throughout the
artery and a mean value obtained. Samples were rando-
mised before assessment and all scores independently
verified by a second blinded assessor. See Additional file 1
for full details on methods used to assess atherosclerosis.
Measurement of blood lipids, C-reactive protein
and fibrinogen
Non-citrated blood was allowed to clot on ice (>2 hours,
4°C), centrifuged (10,000 rpm, 10 min) and used for col-
ormetric measurement of cholesterol and triglycerides
(Microgenics, St Albans, UK), and C-reactive protein (CRP)
by ELISA (Innovative Research kits; Patricell, Nottingham,
UK). Citrated blood was centrifuged (3,000 g, 15 min) to
collect platelet-poor plasma for measurement of fibrino-
gen (Innovative Research ELISA kits; Patricell, UK).
Vascular function
Segments (1–2 mm length) of the distal portion of the
thoracic aorta were mounted in a multi-myograph system
(610M; Danish Myo Technology, Aarhus, Denmark).
Concentration-response curves were generated for phenyl-
ephrine (PE), the endothelium-dependent vasodilator, acetyl-
choline (ACh), and the endothelium-independent nitric
oxide (NO) donor sodium nitroprusside (SNP). Only a
single segment was used from each animal, and all dose
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Drugs were washed out for >30 min, and prior dose re-
sponse curves did not affect the responses to subse-
quent drugs.
Expression of hepatic antioxidants
The expression of tissue mRNA for hemeoxygenase-1
(HO-1), NAD(P)H-quinone oxidoreductase 1 (NQO1),
catalase, and NF-E2-related factor-2 (Nrf2) were measured
by quantitative real-time polymerase chain reaction [9].
Statistical analysis
Statistical comparisons were made using unpaired Student’s
t-test or analysis of variance (ANOVA) with Bonferroni
post-hoc tests where appropriate. Kruskal-Wallis or Mann–
Whitney tests were used for non-parametric or ordinal
level data (1–5 scoring of plaque components). Two-sided
P < 0.05 was taken as statistically significant.
Additional file
Additional file 1: On-line supplementary information.
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